Renin-angiotensin decreases blockade cardiovascular mortality and morbidity of arterial hypertension in primary and secondary prevention. The end of the route?;El bloqueo del sistema renina-angiotensina reduce la mortalidad y morbilidad cardiovascular atribuible a la hipertension arterial en prevencion primaria y secundaria. ?El final del camino?

Medicina Clinica

Volumn 115, Issue 5, 2000, Pages 178-180

  Coca, Antonio ^a   Ruilope, Luis Miguel ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; LISINOPRIL;

CEREBROVASCULAR DISEASE; CLINICAL TRIAL; EDITORIAL; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; PRIMARY PREVENTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SECONDARY PREVENTION; SPAIN;

EID: 0034233535     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(00)71500-4     Document Type: Editorial

References (32)

1. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure
2. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension
3. Blood Pressure, stroke, and coronary heart disease. Part 2. Shortterm reductions in blood pressure. Overview of randomised drug trials in their epidemiological context
4. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
5. The effects of antihypertensive treatment of vascular disease: Reappraisal of the evidence
6. Combination therapy under investigation in large-scale trials: The INVEST study
7. Evolucion del control de la hipertension arterial en Espana. Resultados del estudio Controlpes 98
8. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies
9. Reversal of left ventricular hypertrophy in essential hypertension: A meta-analysis of randomized doubleglind studies
10. Long-term renal preservation in essential hypertension: ACE inhibition superior to beta-blockade
11. Blood pressure control, proteinuria and renal outcome in chronic renal failure
12. Tratamiento antihipertensivo
13. Treatment of Hypertension: Drug therapy
14. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
15. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
16. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58, 050 with suspected acute myocardial infarction
17. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
18. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators
19. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
20. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
21. The effect of langiotensin-converting enzyme therapy on diabetic nephropathy
22. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial
23. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
24. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes
25. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2
26. Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevent on Project (CAPPP) randomised trial
27. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
28. Mortalidad relacionada con la hipertension y la presion arterial en Espana
29. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
30. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial